Trans-dermal Form of Combined HormonalContraception (EVRA®)

Czech version

Authors: M. Fanta
Authors‘ workplace: Gynekologicko-porodnická klinika 1. LF UK a VFN v Praze, přednosta prof. MUDr. J. Živný, DrSc.
Published in: Ceska Gynekol 2003; (5): 341-345
Category:

Overview

Objective:
To present a review of a novel transdermal contraceptive patch containing norelgestromin(150 g/d) and ethinylestradiol (20 g/d).Design: Review article.Setting: Department of Gynecology and Obstetric, 1st Medical Faculty and General Faculty Hospital,Prague.Results: The contraceptive patch exhibits favourable pharmakokinetic profile, maintaining efficaciousserum hormone concentrations under varying conditions and without peaks and throughcharacteristic of oral dosing. Efficacy, cycle control, tolerability and side effect profile were comparableto an established oral contraceptive. Compliance with the weekly administered contraceptivepatch was significantly better than with an oral contraceptive. The reliability of adhesion of thepatch is very high and consistent even under varying conditions (heat, humidity, exercise).

Key words:
transdermal contraception, contraceptive patch, norelgestromin, ethinylestradiol

Full text is not available online.

If interested in a scan of this journal, contact NTO ČLS JEP.

Labels

Paediatric gynaecology Gynaecology and obstetrics Reproduction medicine

Vaginal Birth in Primiparas and Anal Incontinence

Occurence of Congenital Malformationsin the Czech Republic in 2001

Does Decreasing Mortality Increase Serious NeonatalNeurosensoric Morbidity?

May-Hegglin Anomaly in Pregnancy. Two Case Report

A Successfully Postponed Delivery of Twins

Influence of Acute Urological Cases on Courseof Pregnancy

What Can the Bethesda System Give to Gynecologistand What is Expected from Them

Article was published in

Czech Gynaecology

2003 Issue 5